BROWN CAPITAL MANAGEMENT LLC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 09:00 am Sale |
2022-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BROWN CAPITAL MANAGEMENT LLC | 3,997,045 2.610% |
-12,260,854 (-75.41%) |
Filing |
| 2022-02-14 5:02 pm Sale |
2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BROWN CAPITAL MANAGEMENT LLC | 16,257,899 9.930% |
-3,892,564 (-19.32%) |
Filing |
| 2021-02-12 2:55 pm Purchase |
2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
BROWN CAPITAL MANAGEMENT LLC | 20,150,463 12.590% |
2,249,410 (+12.57%) |
Filing |